Changes in observed bloodstream infection epidemiology during a single-set blood culture restriction: an interrupted time series analysis
Joseph B. Ladines-Lim, Bailey Van, Leigh Cressman, Warren B. Bilker, Kathleen O. Degnan, Michael Z. DavidABSTRACT
During the 2024 US national blood culture bottle shortage, many hospitals implemented restrictions limiting blood culture collection to conserve supplies. The impact of these constraints on the microbiologic epidemiology of bloodstream infections (BSIs) remains incompletely characterized. We conducted an interrupted time series analysis of BSI episodes identified at two quaternary hospitals between June 2023 and June 2025, encompassing a systemwide restriction limiting clinicians to one blood culture set per patient every 24 h from June through December 2024. We grouped blood cultures into discrete infection episodes and categorized these by organism group. We normalized monthly incidence rates to acute-care patient-days and used segmented Poisson regression models to estimate changes in incidence associated with restriction onset and withdrawal. We identified 5,391 BSI episodes among 4,484 patients. During the restriction period, the relative proportion of episodes due to enterococci, fungi, gram-negative rods, and
IMPORTANCE
Blood cultures remain the primary method for diagnosing bloodstream infections and tracking causative pathogens. During the 2024 national blood culture bottle shortage, many hospitals limited blood culture collection to conserve supplies. While prior studies focused on changes in testing volume or clinical outcomes, it has remained unclear how these restrictions affected which organisms were ultimately detected. Here, we examined how the shortage influenced the observed distribution of major bloodstream pathogens, including